Breast cancer (from Wikipedia) is cancer that develops from breast tissue. Signs of breast cancer may include lumps in the breast, a change in breast shape, dimpling of the skin, fluid leaking from the nipple, or a red scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.
Data have been loaded from ChEMBL database to configure a ML suited table.
Our BrCa dataset is composed of the activities of compounds assayed on 9 breast cancer cell lines in all DB assays. In this case, for analysis purposes, all cancer data rows have been removed from the master dataset but Breast cancer average potency and flags for each assayed compound have been appended as separate columns to configure class descriptors.
Description | Activity Count |
A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | 68635 |
NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line. | 28705 |
NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line. | 28635 |
NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line. | 28420 |
NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line. | 27872 |
NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. | 27827 |
NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line. | 26627 |
NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line. | 26576 |
NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line. | 25375 |